Close Close
Sign In
Newsletters
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
Podcast Center Video Center Webcasts Resource Center Events
About ThinkAdvisor Contact Us Advertise With Us Asset & Logo Licensing Sitemap Terms of Service Privacy Policy Copyright © 2024 ALM Global, LLC. All Rights Reserved.
ThinkAdvisor

Life Health > Health Insurance

AFLAC Quacks About Higher Profits

By Staff Writer

X
Your article was successfully shared with the contacts you provided.

NU Online News Service, April 29, 2004, 6:07 p.m. EDT – The weak dollar, strong sales of health insurance in Japan and improving sales of supplemental products in the United States are giving AFLAC Inc., Columbus, Ohio, something to quack about.[@@]

The company, which used to be best known for developing the Japanese cancer insurance market and now is known for using a spokesduck to promote accidental death and disability insurance, is reporting $315 million in net income for the quarter on $3.3 billion in revenue, up from $237 million in net income on $2.8 billion in revenue.

The fall of the dollar is helping AFLAC’s net results by increasing the dollar value of its Japanese earnings.

Although sales of a major policy rider and sales through an alliance with a Japanese life insurance company were soft, demand for stand-alone health insurance was strong as a result of the ongoing shift of the Japanese health finance system to more reliance on private insurance. Sales of stand-alone medical products accounted for about 33% of the company’s new sales in Japan, AFLAC says.

In the United States, new training and expansion of the sales force contributed to a 14% increase in premiums from new product sales, AFLAC says.

AD&D accounted for 52% of first-quarter sales in the United States.

NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.